Signal Transduction by the Microtubule Destabilizer, Stathmin/Oncoprotein 18
Signal Transduction by the Microtubule Destabilizer, Stathmin/Oncoprotein 18
批准号:
8231184
负责人:
LYNNE CASSIMERIS
金额:
$36.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-03-01 至 2015-09-28
关键词:
AddressApoptosisBindingBypassCell CycleCell Cycle ProgressionCell Cycle RegulationCell DeathCell ProliferationCell SurvivalCell divisionCellsClinicCommitCyclin BCyclinsCytoskeletonDataDevelopmentDrug Delivery SystemsEnzymesG2 PhaseGoalsGrowthHumanInterphaseInterphase CellInterventionLinkMalignant NeoplasmsMeasuresMentorsMicrotubule DepolymerizationMicrotubule StabilizationMicrotubulesMitosisMitoticModelingMutateMutationNormal CellPaclitaxelPathway interactionsPharmaceutical PreparationsPhasePopulationProcessProtein p53ProteinsPublicationsRegulationRegulatory PathwayReproductionRoleSTAT3 geneSignal PathwaySignal TransductionStudentsTestingTimeToxic effectWorkalternative treatmentcancer cellchemotherapycyclin A2depolymerizationdesigngraduate studenthuman STK6 proteininsightkillingsneoplastic cellprotein functionresearch studyrhorho GTP-Binding Proteinsstathminsuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The control of cell proliferation and survival are critical factors in maintaining healthy cell populations and eliminating those cells defective in proper cell cycle control. A key protein regulating the cell cycle and apoptosis is p53, a protein mutated in >50% of human cancers. We recently found that the combined loss of both p53 and stathmin, a microtubule destabilizing protein, results in a cell cycle delay during the G2 phase of the cell cycle and cell death by apoptosis. These data provide insight into controls governing cell proliferation and hold the potential to identify targets to kill specifically those tumor cells lacking functional p53. Experiments proposed in this application look to identify the signal pathway linking reduced stathmin level and delayed progression through the G2 phase of the cell cycle. Completion of the proposed aims will test the hypothesis that stathmin depletion stabilizes the interphase microtubule cytoskeleton, which acts downstream to limit Rho-dependent activation of Aurora A and mitotic entry. Throughout the aims, alternative models are also tested. In Aim 1, the signal relay downstream of stathmin depletion will be identified. Drug-induced microtubule depolymerization or stabilization will be used to test for their ability to abrogate (depolymerization) or mimic (stabilization) the observed delay in G2. The other stathmin binding partners, p27Kip1 and STAT3, will be tested for their potential role(s) in regulating cell cycle progression after stathmin depletion. Over-expression of stathmin truncations will be used to further probe for microtubule- dependent or -independent regulation of interphase cell cycle progression. In Aim 2, pathways controlling mitotic entry will be examined for their role in relaying signals after stathmin depletion. The levels of cyclins and their rate of accumulation will be measured, the activity states of enzymes directly controlling mitotic entry will be examined, and finally, upstream signal cascades will be manipulated to either abrogate or mimic the stathmin depletion-induced delay in G2. Completion of the two aims will identify the signal cascade linking stathmin depletion and mitotic entry.
PUBLIC HEALTH RELEVANCE: Controlling cancer cell proliferation requires interventions that can block cell replication, ideally without impacting the non-transformed cells in the body. We have identified the microtubule destabilizing protein, stathmin, as a protein necessary for reproduction and survival of cancer cells lacking the tumor suppressor p53. Since about half of all human cancers harbor mutations in p53, understanding why stathmin is required for cell proliferation in these cells holds great potential for selectively controlling their growth.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Stathmin and microtubules regulate mitotic entry in HeLa cells by controlling activation of both Aurora kinase A and Plk1.
Stathmin 和微管通过控制 Aurora 激酶 A 和 Plk1 的激活来调节 HeLa 细胞的有丝分裂进入。
DOI:
10.1091/mbc.e13-02-0108
发表时间:
2013
期刊:
Molecular biology of the cell
影响因子:
3.3
作者:
[Silva,VictoriaC, Cassimeris,Lynne]
通讯作者:
Cassimeris,Lynne
DOI:
10.1002/cm.21024
发表时间:
2012-05
期刊:
CYTOSKELETON
影响因子:
2.9
作者:
[Carney, Bruce K., Silva, Victoria Caruso, Cassimeris, Lynne]
通讯作者:
Cassimeris, Lynne
DOI:
10.1080/15384101.2015.1007781
发表时间:
2015
期刊:
Cell cycle (Georgetown, Tex.)
影响因子:
--
作者:
[Silva VC, Plooster M, Leung JC, Cassimeris L]
通讯作者:
Cassimeris L
DOI:
10.1016/j.devcel.2014.01.025
发表时间:
2014-02-10
期刊:
DEVELOPMENTAL CELL
影响因子:
11.8
作者:
[Silva, Victoria C., Cassimeris, Lynne]
通讯作者:
Cassimeris, Lynne
Microtubule reorganization between interphase and mitosis
-
批准号:9021879
-
项目类别:
-
资助金额:$39.35万
-
财政年份:2015
-
负责人:LYNNE CASSIMERIS
-
依托单位:
MECHANISMS OF MICROTUBULE AND MITOTIC SPINDLE ASSEMBLY
-
批准号:2853632
-
项目类别:
-
资助金额:$31.14万
-
财政年份:1999
-
负责人:LYNNE CASSIMERIS
-
依托单位:
Mechanisms of Microtubule and Mitotic Spindle Assembly
-
批准号:7116376
-
项目类别:
-
资助金额:$34.66万
-
财政年份:1999
-
负责人:LYNNE CASSIMERIS
-
依托单位:
Mechanisms of Microtubule and Mitotic Spindle Assembly
-
批准号:6932467
-
项目类别:
-
资助金额:$35.02万
-
财政年份:1999
-
负责人:LYNNE CASSIMERIS
-
依托单位:
MECHANISMS OF MICROTUBULE AND MITOTIC SPINDLE ASSEMBLY
-
批准号:6519914
-
项目类别:
-
资助金额:$25.61万
-
财政年份:1999
-
负责人:LYNNE CASSIMERIS
-
依托单位:
MECHANISMS OF MICROTUBULE AND MITOTIC SPINDLE ASSEMBLY
-
批准号:6386973
-
项目类别:
-
资助金额:$24.88万
-
财政年份:1999
-
负责人:LYNNE CASSIMERIS
-
依托单位:
Mechanisms of Microtubule and Mitotic Spindle Assembly
-
批准号:6679274
-
项目类别:
-
资助金额:$35.93万
-
财政年份:1999
-
负责人:LYNNE CASSIMERIS
-
依托单位:
MECHANISMS OF MICROTUBULE AND MITOTIC SPINDLE ASSEMBLY
-
批准号:6180857
-
项目类别:
-
资助金额:$24.17万
-
财政年份:1999
-
负责人:LYNNE CASSIMERIS
-
依托单位:
Mechanisms of Microtubule and Mitotic Spindle Assembly
-
批准号:6785325
-
项目类别:
-
资助金额:$35.04万
-
财政年份:1999
-
负责人:LYNNE CASSIMERIS
-
依托单位:
REGULATION OF MICROTUBULE DYNAMIC INSTABILITY
-
批准号:2187298
-
项目类别:
-
资助金额:$10.51万
-
财政年份:1993
-
负责人:LYNNE CASSIMERIS
-
依托单位:
REGULATION OF MICROTUBULE DYNAMIC INSTABILITY
-
批准号:2187299
-
项目类别:
-
资助金额:$10.96万
-
财政年份:1993
-
负责人:LYNNE CASSIMERIS
-
依托单位:
REGULATION OF MICROTUBULE DYNAMIC INSTABILITY
-
批准号:2864749
-
项目类别:
-
资助金额:$3.83万
-
财政年份:1993
-
负责人:LYNNE CASSIMERIS
-
依托单位:
REGULATION OF MICROTUBULE DYNAMIC INSTABILITY
-
批准号:3469117
-
项目类别:
-
资助金额:$10.07万
-
财政年份:1993
-
负责人:LYNNE CASSIMERIS
-
依托单位:
REGULATION OF MICROTUBULE DYNAMIC INSTABILITY
-
批准号:2187297
-
项目类别:
-
资助金额:$10.18万
-
财政年份:1993
-
负责人:LYNNE CASSIMERIS
-
依托单位:
REGULATION OF MICROTUBULE DYNAMIC INSTABILITY
-
批准号:2459494
-
项目类别:
-
资助金额:$11.46万
-
财政年份:1993
-
负责人:LYNNE CASSIMERIS
-
依托单位:
3D ULTRASTRUCTURAL RECONSTRUCTION OF MICROTUBULES
-
批准号:3851854
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:LYNNE CASSIMERIS
-
依托单位:
3D ULTRASTRUCTURAL RECONSTRUCTION OF MICROTUBULES
-
批准号:3866453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:LYNNE CASSIMERIS
-
依托单位:
3D ULTRASTRUCTURAL RECONSTRUCTION OF MICROTUBULES
-
批准号:3788236
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:LYNNE CASSIMERIS
-
依托单位:
3D ULTRASTRUCTURAL RECONSTRUCTION OF MICROTUBULES
-
批准号:3887553
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:LYNNE CASSIMERIS
-
依托单位:
3D ULTRASTRUCTURAL RECONSTRUCTION OF MICROTUBULES
-
批准号:3766162
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:LYNNE CASSIMERIS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: